A detailed history of Manufacturers Life Insurance Company, The transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 413,269 shares of ACAD stock, worth $7.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
413,269
Previous 462,078 10.56%
Holding current value
$7.05 Million
Previous $7.51 Million 15.29%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.14 - $19.14 $738,968 - $934,204
-48,809 Reduced 10.56%
413,269 $6.36 Million
Q2 2024

Aug 14, 2024

SELL
$14.62 - $18.42 $10.4 Million - $13.1 Million
-709,546 Reduced 60.56%
462,078 $7.51 Million
Q1 2024

May 14, 2024

BUY
$17.79 - $30.86 $5.79 Million - $10 Million
325,596 Added 38.49%
1,171,624 $21.7 Million
Q4 2023

Feb 13, 2024

SELL
$20.78 - $31.77 $4.25 Million - $6.49 Million
-204,366 Reduced 19.46%
846,028 $26.5 Million
Q3 2023

Nov 15, 2023

BUY
$20.84 - $33.47 $2.86 Million - $4.6 Million
137,369 Added 15.05%
1,050,394 $21.9 Million
Q2 2023

Aug 11, 2023

SELL
$17.8 - $25.65 $289,285 - $416,863
-16,252 Reduced 1.75%
913,025 $21.9 Million
Q1 2023

May 15, 2023

SELL
$16.32 - $20.92 $933,944 - $1.2 Million
-57,227 Reduced 6.16%
872,050 $16.4 Million
Q4 2022

Aug 11, 2023

BUY
$14.2 - $18.63 $182,881 - $239,935
12,879 Added 1.41%
929,277 $14.8 Million
Q4 2022

Feb 13, 2023

BUY
$14.2 - $18.63 $212,091 - $278,257
14,936 Added 1.63%
929,277 $14.8 Million
Q3 2022

Aug 11, 2023

BUY
$14.11 - $18.27 $160,642 - $208,003
11,385 Added 1.26%
916,398 $15 Million
Q3 2022

Nov 03, 2022

BUY
$14.11 - $18.27 $131,618 - $170,422
9,328 Added 1.03%
914,341 $14.9 Million
Q2 2022

Aug 11, 2023

BUY
$13.01 - $27.22 $388,881 - $813,633
29,891 Added 3.42%
905,013 $12.8 Million
Q2 2022

Aug 15, 2022

BUY
$13.01 - $27.22 $388,881 - $813,633
29,891 Added 3.42%
905,013 $12.8 Million
Q1 2022

Aug 11, 2023

BUY
$20.94 - $27.5 $64,327 - $84,480
3,072 Added 0.35%
875,122 $21.2 Million
Q1 2022

May 20, 2022

BUY
$20.94 - $27.5 $1.7 Million - $2.23 Million
81,222 Added 10.23%
875,122 $21.2 Million
Q4 2021

Feb 16, 2022

SELL
$16.79 - $27.09 $3.8 Million - $6.13 Million
-226,360 Reduced 22.19%
793,900 $18.5 Million
Q3 2021

Nov 12, 2021

BUY
$15.78 - $24.77 $480,453 - $754,172
30,447 Added 3.08%
1,020,260 $16.9 Million
Q2 2021

Aug 12, 2021

BUY
$19.4 - $27.42 $7.37 Million - $10.4 Million
380,003 Added 62.31%
989,813 $24.1 Million
Q1 2021

May 03, 2021

BUY
$25.02 - $54.99 $8.18 Million - $18 Million
326,895 Added 115.55%
609,810 $15.7 Million
Q4 2020

Feb 12, 2021

BUY
$41.04 - $56.79 $11.6 Million - $16.1 Million
282,915 New
282,915 $15.1 Million
Q2 2020

Aug 10, 2020

SELL
$39.26 - $52.73 $2.83 Million - $3.8 Million
-72,006 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$31.65 - $46.87 $255,542 - $378,428
8,074 Added 12.63%
72,006 $3.04 Million
Q4 2019

Feb 14, 2020

SELL
$36.21 - $51.4 $72,890 - $103,468
-2,013 Reduced 3.05%
63,932 $2.74 Million
Q3 2019

Nov 12, 2019

SELL
$22.22 - $44.01 $1,755 - $3,476
-79 Reduced 0.12%
65,945 $2.43 Million
Q2 2019

Aug 14, 2019

SELL
$23.32 - $28.12 $189,218 - $228,165
-8,114 Reduced 10.94%
66,024 $1.77 Million
Q1 2019

May 13, 2019

BUY
$16.17 - $27.38 $211,535 - $358,185
13,082 Added 21.43%
74,138 $1.99 Million
Q4 2018

Feb 14, 2019

BUY
$14.32 - $22.92 $462,278 - $739,903
32,282 Added 112.19%
61,056 $987,000
Q3 2018

Nov 14, 2018

SELL
$13.03 - $21.81 $599,901 - $1 Million
-46,040 Reduced 61.54%
28,774 $597,000
Q2 2018

Aug 14, 2018

SELL
$15.07 - $22.34 $936,841 - $1.39 Million
-62,166 Reduced 45.38%
74,814 $1.14 Million
Q1 2018

May 15, 2018

BUY
$22.47 - $32.33 $2.99 Million - $4.3 Million
132,946 Added 3295.64%
136,980 $3.08 Million
Q4 2017

Feb 08, 2018

SELL
$26.84 - $39.14 $9,286 - $13,542
-346 Reduced 7.9%
4,034 $121,000
Q3 2017

Nov 14, 2017

BUY
$29.49 - $38.37 $129,166 - $168,060
4,380
4,380 $165,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.